Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1961 1
1962 1
1963 1
1965 1
1990 1
1993 3
1994 1
2006 2
2015 4
2016 12
2017 18
2018 18
2019 9
2020 6
2021 13
2022 10
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada.
Lima VD, Brumme ZL, Brumme C, Sereda P, Krajden M, Wong J, Guillemi SA, Henry B, Hogg RS, Barrios R, Montaner JSG; STOP HIV/AIDS Study Group. Lima VD, et al. Among authors: sereda p. Curr HIV/AIDS Rep. 2020 Apr;17(2):77-87. doi: 10.1007/s11904-020-00482-6. Curr HIV/AIDS Rep. 2020. PMID: 32124189 Free PMC article. Review.
Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART.
Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Speckmaier S, Barad E, Moran-Garcia N, Datwani S, Duncan MC, Kalikawe R, Ennis S, Young L, Ganase B, Omondi FH, Umviligihozo G, Dong W, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, Demarco ML, Simons J, Hedgcock M, Prystajecky N, Lowe CF, Romney MG, Barrios R, Guillemi S, Brumme CJ, Montaner JSG, Hull M, Harris M, Niikura M, Brockman MA, Brumme ZL. Lapointe HR, et al. Among authors: sereda p. AIDS. 2022 Dec 23. doi: 10.1097/QAD.0000000000003469. Online ahead of print. AIDS. 2022. PMID: 36545783
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg R, Cooper CL; Canadian Observational Cohort (CANOC) Collaboration. Rana U, et al. Among authors: sereda p. BMC Infect Dis. 2019 Nov 21;19(1):982. doi: 10.1186/s12879-019-4617-8. BMC Infect Dis. 2019. PMID: 31752729 Free PMC article.
Tobacco smoking and HIV-related immunologic and virologic response among individuals of the Canadian HIV Observational Cohort (CANOC).
McClean AR, Kooij KW, Trigg J, Ye M, Sereda P, McLinden T, Bacani N, Aran N, Thomas R, Wong A, Klein MB, Hull M, Cooper C, Salters K, Hogg RS; CANOC Collaboration. McClean AR, et al. Among authors: sereda p. AIDS Care. 2022 Aug;34(8):982-991. doi: 10.1080/09540121.2021.1929813. Epub 2021 Jun 1. AIDS Care. 2022. PMID: 34074181
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.
Brumme ZL, Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Duncan MC, Yaseen F, Agafitei O, Ennis S, Ng K, Basra S, Lim LY, Kalikawe R, Speckmaier S, Moran-Garcia N, Young L, Ali H, Ganase B, Umviligihozo G, Omondi FH, Atkinson K, Sudderuddin H, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, DeMarco ML, Simons J, Hedgcock M, Romney MG, Barrios R, Guillemi S, Brumme CJ, Pantophlet R, Montaner JSG, Niikura M, Harris M, Hull M, Brockman MA. Brumme ZL, et al. Among authors: sereda p. NPJ Vaccines. 2022 Feb 28;7(1):28. doi: 10.1038/s41541-022-00452-6. NPJ Vaccines. 2022. PMID: 35228535 Free PMC article.
Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patients.
Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg R, Cooper CL. Rana U, et al. Among authors: sereda p. J Assoc Med Microbiol Infect Dis Can. 2021 Jul 20;6(2):137-148. doi: 10.3138/jammi-2020-0011. eCollection 2021 Jun. J Assoc Med Microbiol Infect Dis Can. 2021. PMID: 36341035 Free PMC article.
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.
Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Speckmaier S, Moran-Garcia N, Datwani S, Duncan MC, Agafitei O, Ennis S, Young L, Ali H, Ganase B, Omondi FH, Dong W, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, DeMarco ML, Simons J, Hedgcock M, Prystajecky N, Lowe CF, Pantophlet R, Romney MG, Barrios R, Guillemi S, Brumme CJ, Montaner JSG, Hull M, Harris M, Niikura M, Brockman MA, Brumme ZL. Lapointe HR, et al. Among authors: sereda p. medRxiv. 2022 Mar 23:2022.03.22.22272793. doi: 10.1101/2022.03.22.22272793. Preprint. medRxiv. 2022. PMID: 35350205 Free PMC article. Updated.
Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada.
Thompson KA, Blank G, Toy J, Moore DM, Lachowsky N, Bacani N, Zhang W, Sereda P, Lima VD, Barrios R, Montaner JSG, Hull MW. Thompson KA, et al. Among authors: sereda p. Open Forum Infect Dis. 2021 Oct 6;8(11):ofab492. doi: 10.1093/ofid/ofab492. eCollection 2021 Nov. Open Forum Infect Dis. 2021. PMID: 34805433 Free PMC article.
93 results